US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Longeveron Inc

0.5401

+0.02715.28%

Volume:102.16K

Turnover:54.42K

Market Cap:11.52M

PE:-0.40

High:0.5519

Open:0.5050

Low:0.5050

Close:0.5130

52wk High:1.92

52wk Low:0.4920

Shares:21.33M

Float Shares:16.75M

Volume Ratio:0.55

T/O Rate:0.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3485

EPS(LYR):-2.6164

ROE:-119.92%

ROA:-60.95%

PB:1.16

PE(LYR):-0.21

Loading ...

Overview Company News Filings

Longeveron ‘applauds’ Mikaela Naylon Give Kids a Chance Act passage

Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program

Longeveron granted Japan patent for potency assay methods for MSCs

Longeveron Granted Japan Patent for Potency Assay Methods for Human Mesenchymal Stem Cells

Longeveron granted FDA Type C Meeting ahead of ELPIS II data readout

Longeveron Inc - Elpis Ii Trial Results Anticipated in Q3 2026

THOMSON REUTERS

Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using Its Proprietary Stem Cell Therapy

THOMSON REUTERS

Longeveron Granted U.S. Patent for Stem Cell Therapy to Treat Female Sexual Dysfunction

Longeveron Executives Speak at Global CardioVascular Clinical Trialists Forum

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global Cardiovascular Clinical Trialists (Cvct) Forum

THOMSON REUTERS

Longeveron Granted Canadian Patent for Stem Cell Therapy Targeting Aging-Related Frailty and Cardiomyopathy

Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-Related Frailty in Patients With Inflammaging

THOMSON REUTERS

Longeveron Stem Cell Therapy Reduces Neuroinflammation in Mild Alzheimer’s Disease, Phase 2 Trial Shows

Longeveron New Mri Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients With Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (Ctad 2025)

THOMSON REUTERS

Longeveron Highlights Laromestrocel Data Showing Reduced Brain Neuroinflammation in Mild Alzheimer’s Disease

Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (Ctad 2025)

THOMSON REUTERS

Longeveron granted U.S. patent for administration of MSCs

Longeveron Granted U.S. Patent for Stem Cell Therapy Targeting Aging-Related Frailty

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LGVN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LGVN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGVN\",,,,,undefined,":{"symbol":"LGVN","market":"US","secType":"STK","nameCN":"Longeveron Inc","latestPrice":0.5401,"timestamp":1770670800000,"preClose":0.513,"halted":0,"volume":102155,"delay":0,"changeRate":0.05282651072124759,"floatShares":16753800,"shares":21332900,"eps":-1.348531,"marketStatus":"Pre-Mkt","change":0.0271,"latestTime":"02-10 04:29:34 EST","open":0.505,"high":0.5519,"low":0.505,"amount":54422.529720750004,"amplitude":0.091423,"askPrice":0.6012,"askSize":100,"bidPrice":0.4756,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.348531,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"listingDate":1613106000000,"exchange":"NASDAQ","adjPreClose":0.5401,"postHourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5401,"latestTime":"19:22 EST","volume":694,"amount":374.924,"timestamp":1770682936201,"change":-0.0001,"changeRate":-0.000185,"amplitude":0.003703},"volumeRatio":0.5545139519451399},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGVN\",,,,,undefined,":{"symbol":"LGVN","floatShares":16753800,"roa":"-60.95%","roe":"-119.92%","lyrEps":-2.61636,"volumeRatio":0.5545139519451399,"shares":21332900,"dividePrice":0,"high":0.5519,"amplitude":0.091423,"preClose":0.513,"low":0.505,"week52Low":0.492,"pbRate":"1.16","psRate":"8.02","week52High":1.9198,"institutionHeld":0,"latestPrice":0.5401,"eps":-1.348531,"divideRate":0,"volume":102155,"delay":0,"ttmEps":-1.348531,"open":0.505,"prevYearClose":0.506,"prevWeekClose":0.513,"prevMonthClose":0.5597,"prevQuarterClose":0.506,"fiveDayClose":0.536,"twentyDayClose":0.6233,"sixtyDayClose":0.7171},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGVN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"LGVN","fiscalQuarterEnding":"2024/12","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"post","actualEps":-2.5},{"market":"US","date":"2024-11-12","symbol":"LGVN","fiscalQuarterEnding":"2024/09","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-05-14","symbol":"LGVN","fiscalQuarterEnding":"2024/03","expectedEps":-2.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-1.61},{"market":"US","date":"2024-03-27","symbol":"LGVN","defaultRemindTime":1711546200000,"type":"split","dateTimestamp":1711512000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2023-08-18","symbol":"LGVN","defaultRemindTime":1692365400000,"type":"split","dateTimestamp":1692331200000,"forFactor":1040792,"toFactor":1000000,"ratio":1.040792}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGVN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGVN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1733634000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LGVN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LGVN","date":"2026-02-06","current":-0.40051,"percent":0.961758,"low":-65.336046,"twenty":-8.919918,"median":-3.082252,"eighty":-1.09839,"high":-0.238289,"avg":-6.750407,"sd":10.007253,"marketCap":10901102},"quantilePoints":[{"date":"2021-02-12","current":-48.831667,"twenty":-61.328463,"median":-55.317089,"eighty":-51.425836,"marketCap":138618210},{"date":"2021-02-19","current":-40.594206,"twenty":-54.151804,"median":-48.831667,"eighty":-45.207185,"marketCap":115234571},{"date":"2021-02-26","current":-52.719749,"twenty":-52.258451,"median":-48.666918,"eighty":-44.877686,"marketCap":149655288},{"date":"2021-03-05","current":-45.009486,"twenty":-52.61431,"median":-48.831667,"eighty":-45.035846,"marketCap":127768202},{"date":"2021-03-12","current":-53.510545,"twenty":-53.352386,"median":-48.666918,"eighty":-45.194005,"marketCap":151900117},{"date":"2021-03-19","current":-47.948307,"twenty":-52.61431,"median":-49.016793,"eighty":-45.418064,"marketCap":136110620},{"date":"2021-03-26","current":-39.266859,"twenty":-52.166192,"median":-48.49236,"eighty":-45.035846,"marketCap":111466636},{"date":"2021-04-01","current":-33.063787,"twenty":-52.060752,"median":-47.665091,"eighty":-41.136709,"marketCap":123030352},{"date":"2021-04-09","current":-34.694051,"twenty":-50.619522,"median":-46.12978,"eighty":-37.797691,"marketCap":129096563},{"date":"2021-04-16","current":-33.216624,"twenty":-50.419181,"median":-45.437833,"eighty":-35.254454,"marketCap":123599059},{"date":"2021-04-23","current":-30.057988,"twenty":-50.41326,"median":-45.009486,"eighty":-33.62419,"marketCap":111845774},{"date":"2021-04-30","current":-31.331632,"twenty":-49.490664,"median":-41.755104,"eighty":-33.063787,"marketCap":116585002},{"date":"2021-05-07","current":-28.47867,"twenty":-49.283915,"median":-40.594206,"eighty":-31.433523,"marketCap":105969132},{"date":"2021-05-14","current":-15.200628,"twenty":-49.016793,"median":-37.978026,"eighty":-31.076903,"marketCap":100612958},{"date":"2021-05-21","current":-18.326795,"twenty":-48.831667,"median":-36.37526,"eighty":-30.007042,"marketCap":121305057},{"date":"2021-05-28","current":-18.929084,"twenty":-48.502169,"median":-34.617632,"eighty":-28.071104,"marketCap":125291608},{"date":"2021-06-04","current":-19.33061,"twenty":-48.486474,"median":-33.878919,"eighty":-26.899352,"marketCap":127949308},{"date":"2021-06-11","current":-20.248384,"twenty":-48.055156,"median":-33.318516,"eighty":-19.405179,"marketCap":134024053},{"date":"2021-06-18","current":-20.64991,"twenty":-47.495161,"median":-32.758112,"eighty":-19.405179,"marketCap":136681754},{"date":"2021-06-25","current":-22.514138,"twenty":-46.432919,"median":-31.484469,"eighty":-19.62315,"marketCap":149021079},{"date":"2021-07-02","current":-23.804757,"twenty":-46.14296,"median":-31.22974,"eighty":-19.881274,"marketCap":157563689},{"date":"2021-07-09","current":-21.424282,"twenty":-45.738372,"median":-31.076903,"eighty":-20.12219,"marketCap":141807320},{"date":"2021-07-16","current":-18.01131,"twenty":-45.473443,"median":-30.210826,"eighty":-19.571525,"marketCap":119216863},{"date":"2021-07-23","current":-17.753186,"twenty":-45.431244,"median":-29.675895,"eighty":-19.238833,"marketCap":117508341},{"date":"2021-07-30","current":-16.462567,"twenty":-45.246725,"median":-28.47867,"eighty":-18.946292,"marketCap":108965731},{"date":"2021-08-06","current":-16.921454,"twenty":-45.062206,"median":-27.485228,"eighty":-18.625072,"marketCap":112003104},{"date":"2021-08-13","current":-7.15835,"twenty":-44.890866,"median":-26.491786,"eighty":-17.999838,"marketCap":74547057},{"date":"2021-08-20","current":-6.552643,"twenty":-43.348813,"median":-23.532293,"eighty":-17.667145,"marketCap":68239229},{"date":"2021-08-27","current":-6.479224,"twenty":-41.631425,"median":-22.973025,"eighty":-17.414758,"marketCap":67474643},{"date":"2021-09-03","current":-6.864674,"twenty":-41.056573,"median":-22.169973,"eighty":-16.909982,"marketCap":71488716},{"date":"2021-09-10","current":-6.846319,"twenty":-40.839572,"median":-21.625045,"eighty":-16.577289,"marketCap":71297569},{"date":"2021-09-17","current":-6.644417,"twenty":-40.063267,"median":-21.280879,"eighty":-16.330637,"marketCap":69194960},{"date":"2021-09-24","current":-6.791255,"twenty":-38.82346,"median":-20.965394,"eighty":-15.326822,"marketCap":70724131},{"date":"2021-10-01","current":-6.699481,"twenty":-38.014093,"median":-20.64991,"eighty":-7.048222,"marketCap":69768399},{"date":"2021-10-08","current":-6.277322,"twenty":-37.595528,"median":-20.305745,"eighty":-6.864674,"marketCap":65372034},{"date":"2021-10-15","current":-7.305188,"twenty":-36.925474,"median":-19.674775,"eighty":-6.853661,"marketCap":76076227},{"date":"2021-10-22","current":-6.185549,"twenty":-35.926938,"median":-19.34495,"eighty":-6.813281,"marketCap":64416303},{"date":"2021-10-29","current":-6.332386,"twenty":-35.030293,"median":-19.101167,"eighty":-6.706823,"marketCap":65945473},{"date":"2021-11-05","current":-7.15835,"twenty":-34.632916,"median":-18.979275,"eighty":-6.706823,"marketCap":74547057},{"date":"2021-11-12","current":-4.536013,"twenty":-34.378188,"median":-18.929084,"eighty":-6.677456,"marketCap":65010142},{"date":"2021-11-19","current":-13.381239,"twenty":-33.929865,"median":-18.584919,"eighty":-6.651759,"marketCap":191779918},{"date":"2021-11-26","current":-40.917508,"twenty":-34.663484,"median":-18.871723,"eighty":-6.662772,"marketCap":586429722},{"date":"2021-12-03","current":-28.484032,"twenty":-34.955363,"median":-18.957764,"eighty":-6.670114,"marketCap":408233150},{"date":"2021-12-10","current":-27.507194,"twenty":-34.663484,"median":-19.086827,"eighty":-6.699481,"marketCap":394233106},{"date":"2021-12-17","current":-24.619151,"twenty":-34.459701,"median":-19.33061,"eighty":-6.699481,"marketCap":352841674},{"date":"2021-12-23","current":-19.395191,"twenty":-34.133648,"median":-19.395191,"eighty":-6.699481,"marketCap":277971876},{"date":"2021-12-31","current":-17.087588,"twenty":-33.62419,"median":-19.33061,"eighty":-6.717836,"marketCap":244899310},{"date":"2022-01-07","current":-13.718204,"twenty":-33.573245,"median":-19.072486,"eighty":-6.754546,"marketCap":196609305},{"date":"2022-01-14","current":-12.854623,"twenty":-33.318516,"median":-18.943424,"eighty":-6.791255,"marketCap":184232455},{"date":"2022-01-21","current":-9.315354,"twenty":-33.237002,"median":-18.871723,"eighty":-6.791255,"marketCap":133507660},{"date":"2022-01-28","current":-9.980737,"twenty":-33.094354,"median":-18.384156,"eighty":-6.820623,"marketCap":143043921},{"date":"2022-02-04","current":-10.561177,"twenty":-32.574708,"median":-18.169052,"eighty":-6.842648,"marketCap":151362788},{"date":"2022-02-11","current":-9.86748,"twenty":-31.881846,"median":-17.937012,"eighty":-6.861003,"marketCap":141420728},{"date":"2022-02-18","current":-9.088841,"twenty":-31.535415,"median":-17.710166,"eighty":-6.864674,"marketCap":130261273},{"date":"2022-02-25","current":-8.749072,"twenty":-31.453901,"median":-17.660508,"eighty":-6.8867,"marketCap":125391693},{"date":"2022-03-04","current":-8.720757,"twenty":-31.372388,"median":-17.581104,"eighty":-6.901384,"marketCap":124985894},{"date":"2022-03-11","current":-8.219862,"twenty":-31.209362,"median":-17.333064,"eighty":-6.934422,"marketCap":140107545},{"date":"2022-03-18","current":-8.416157,"twenty":-31.097281,"median":-17.087588,"eighty":-6.956448,"marketCap":143453397},{"date":"2022-03-25","current":-8.268936,"twenty":-31.076903,"median":-16.921454,"eighty":-6.967461,"marketCap":140944008},{"date":"2022-04-01","current":-19.151051,"twenty":-31.033156,"median":-16.921454,"eighty":-6.985815,"marketCap":326429670},{"date":"2022-04-08","current":-11.728639,"twenty":-30.803199,"median":-16.83276,"eighty":-6.993157,"marketCap":199914647},{"date":"2022-04-14","current":-12.03535,"twenty":-30.485933,"median":-16.60597,"eighty":-7.000499,"marketCap":205142540},{"date":"2022-04-22","current":-15.163805,"twenty":-30.149691,"median":-16.462567,"eighty":-7.04088,"marketCap":258467054},{"date":"2022-04-29","current":-12.292987,"twenty":-30.03761,"median":-16.347845,"eighty":-7.114299,"marketCap":209533971},{"date":"2022-05-06","current":-10.268693,"twenty":-29.742124,"median":-16.290485,"eighty":-7.15835,"marketCap":175029874},{"date":"2022-05-13","current":-9.602157,"twenty":-29.283613,"median":-15.640536,"eighty":-7.15835,"marketCap":167500032},{"date":"2022-05-20","current":-9.830208,"twenty":-28.982376,"median":-15.171948,"eighty":-7.160402,"marketCap":171478157},{"date":"2022-05-27","current":-9.662171,"twenty":-28.594457,"median":-14.735002,"eighty":-7.213071,"marketCap":168546907},{"date":"2022-06-03","current":-10.478354,"twenty":-28.48296,"median":-14.280476,"eighty":-7.291006,"marketCap":182784409},{"date":"2022-06-10","current":-8.605933,"twenty":-28.397157,"median":-13.986034,"eighty":-7.348262,"marketCap":150121903},{"date":"2022-06-17","current":-7.225623,"twenty":-28.000793,"median":-13.490192,"eighty":-7.348262,"marketCap":126043774},{"date":"2022-06-24","current":-8.149831,"twenty":-27.71955,"median":-13.34012,"eighty":-7.28746,"marketCap":142165652},{"date":"2022-07-01","current":-7.129602,"twenty":-27.714484,"median":-12.897094,"eighty":-7.237626,"marketCap":124368773},{"date":"2022-07-08","current":-8.689952,"twenty":-27.548652,"median":-12.771457,"eighty":-7.277493,"marketCap":151587528},{"date":"2022-07-15","current":-7.585704,"twenty":-27.306321,"median":-12.480832,"eighty":-7.295604,"marketCap":132325025},{"date":"2022-07-22","current":-7.393661,"twenty":-27.255998,"median":-12.243914,"eighty":-7.303678,"marketCap":128975024},{"date":"2022-07-29","current":-7.47768,"twenty":-27.05219,"median":-11.992411,"eighty":-7.295604,"marketCap":130440649},{"date":"2022-08-05","current":-7.261631,"twenty":-26.986954,"median":-11.728639,"eighty":-7.295604,"marketCap":126671899},{"date":"2022-08-12","current":-6.915094,"twenty":-26.590105,"median":-11.385117,"eighty":-7.261631,"marketCap":124872769},{"date":"2022-08-19","current":-6.13642,"twenty":-25.956359,"median":-10.955726,"eighty":-7.223223,"marketCap":110811465},{"date":"2022-08-26","current":-6.043444,"twenty":-25.233568,"median":-10.809898,"eighty":-7.162453,"marketCap":109132504},{"date":"2022-09-02","current":-5.334501,"twenty":-25.01838,"median":-10.575334,"eighty":-7.129602,"marketCap":96330421},{"date":"2022-09-09","current":-5.903979,"twenty":-24.772047,"median":-10.504549,"eighty":-7.055563,"marketCap":106614061},{"date":"2022-09-16","current":-5.299635,"twenty":-24.568186,"median":-10.355899,"eighty":-6.985815,"marketCap":95700811},{"date":"2022-09-23","current":-4.695291,"twenty":-24.222196,"median":-10.150622,"eighty":-6.90961,"marketCap":84787560},{"date":"2022-09-30","current":-4.300143,"twenty":-23.952453,"median":-10.086915,"eighty":-6.861598,"marketCap":77651974},{"date":"2022-10-07","current":-4.067702,"twenty":-23.847373,"median":-10.023208,"eighty":-6.791255,"marketCap":73454570},{"date":"2022-10-14","current":-4.021214,"twenty":-23.77034,"median":-9.994894,"eighty":-6.699481,"marketCap":72615089},{"date":"2022-10-21","current":-4.207166,"twenty":-23.489272,"median":-9.909952,"eighty":-6.65543,"marketCap":75973012},{"date":"2022-10-28","current":-4.195544,"twenty":-23.145108,"median":-9.827609,"eighty":-6.570998,"marketCap":75763142},{"date":"2022-11-04","current":-3.835262,"twenty":-22.996298,"median":-9.806203,"eighty":-6.534289,"marketCap":69257166},{"date":"2022-11-11","current":-4.544205,"twenty":-22.973244,"median":-9.732066,"eighty":-6.479224,"marketCap":82059248},{"date":"2022-11-18","current":-4.568971,"twenty":-22.886984,"median":-9.640967,"eighty":-6.446186,"marketCap":84283804},{"date":"2022-11-25","current":-4.888001,"twenty":-22.741313,"median":-9.602157,"eighty":-6.405805,"marketCap":90168957},{"date":"2022-12-02","current":-4.284122,"twenty":-22.570963,"median":-9.514769,"eighty":-6.387451,"marketCap":79029202},{"date":"2022-12-09","current":-3.714425,"twenty":-22.444428,"median":-9.458125,"eighty":-6.332386,"marketCap":68520000},{"date":"2022-12-16","current":-3.543516,"twenty":-22.13424,"median":-9.422117,"eighty":-6.284664,"marketCap":65367239},{"date":"2022-12-23","current":-3.725819,"twenty":-21.802864,"median":-9.371983,"eighty":-6.176991,"marketCap":68730184},{"date":"2022-12-30","current":-3.668849,"twenty":-21.711086,"median":-9.315354,"eighty":-6.138904,"marketCap":67679264},{"date":"2023-01-06","current":-4.067637,"twenty":-21.481642,"median":-9.182063,"eighty":-6.043444,"marketCap":75035705},{"date":"2023-01-13","current":-4.215759,"twenty":-21.424282,"median":-9.117155,"eighty":-5.915601,"marketCap":77768098},{"date":"2023-01-20","current":-4.500607,"twenty":-21.30956,"median":-9.000806,"eighty":-5.678512,"marketCap":83022699},{"date":"2023-01-27","current":-4.73988,"twenty":-21.234991,"median":-8.893998,"eighty":-5.548346,"marketCap":87436564},{"date":"2023-02-03","current":-4.603153,"twenty":-21.085853,"median":-8.803446,"eighty":-5.274067,"marketCap":84914356},{"date":"2023-02-10","current":-4.113213,"twenty":-20.91377,"median":-8.720757,"eighty":-4.912766,"marketCap":75876442},{"date":"2023-02-17","current":-4.033455,"twenty":-20.741687,"median":-8.605933,"eighty":-4.827782,"marketCap":74405153},{"date":"2023-02-24","current":-3.93091,"twenty":-20.672854,"median":-8.569513,"eighty":-4.694896,"marketCap":72513497},{"date":"2023-03-03","current":-4.090425,"twenty":-20.598285,"median":-8.416157,"eighty":-4.68291,"marketCap":75456073},{"date":"2023-03-10","current":-3.437042,"twenty":-20.443411,"median":-8.263395,"eighty":-4.603153,"marketCap":64736687},{"date":"2023-03-17","current":-3.126922,"twenty":-20.294273,"median":-8.219862,"eighty":-4.553749,"marketCap":58895578},{"date":"2023-03-24","current":-3.093419,"twenty":-20.059093,"median":-8.166443,"eighty":-4.540928,"marketCap":58264553},{"date":"2023-03-31","current":-2.981744,"twenty":-19.778025,"median":-7.99903,"eighty":-4.512001,"marketCap":56161140},{"date":"2023-04-06","current":-2.8589,"twenty":-19.571525,"median":-7.957788,"eighty":-4.498873,"marketCap":53847385},{"date":"2023-04-14","current":-3.13809,"twenty":-19.408067,"median":-7.93795,"eighty":-4.455031,"marketCap":59105919},{"date":"2023-04-21","current":-3.171592,"twenty":-19.380831,"median":-7.819121,"eighty":-4.404835,"marketCap":59736943},{"date":"2023-04-28","current":-3.13809,"twenty":-19.347819,"median":-7.681726,"eighty":-4.316523,"marketCap":59105919},{"date":"2023-05-05","current":-3.319422,"twenty":-19.33061,"median":-7.645718,"eighty":-4.210603,"marketCap":62521321},{"date":"2023-05-12","current":-3.855895,"twenty":-19.258786,"median":-7.5677,"eighty":-4.188571,"marketCap":72625777},{"date":"2023-05-19","current":-3.341253,"twenty":-19.131097,"median":-7.525445,"eighty":-4.170183,"marketCap":66731511},{"date":"2023-05-26","current":-3.272255,"twenty":-19.089695,"median":-7.447673,"eighty":-4.134387,"marketCap":65353468},{"date":"2023-06-02","current":-3.335589,"twenty":-19.058146,"median":-7.387659,"eighty":-4.092704,"marketCap":66618374},{"date":"2023-06-09","current":-3.683925,"twenty":-18.992181,"median":-7.321645,"eighty":-4.079031,"marketCap":73575356},{"date":"2023-06-16","current":-3.736704,"twenty":-18.952028,"median":-7.321645,"eighty":-4.058522,"marketCap":74629444},{"date":"2023-06-23","current":-3.905594,"twenty":-18.929084,"median":-7.309642,"eighty":-4.044458,"marketCap":78002526},{"date":"2023-06-30","current":-3.588662,"twenty":-18.929084,"median":-7.301414,"eighty":-4.030512,"marketCap":71672749},{"date":"2023-07-07","current":-3.175807,"twenty":-18.860251,"median":-7.29255,"eighty":-4.013656,"marketCap":63427212},{"date":"2023-07-14","current":-3.546317,"twenty":-18.797154,"median":-7.261631,"eighty":-3.988563,"marketCap":70827053},{"date":"2023-07-21","current":-3.662764,"twenty":-18.544766,"median":-7.231624,"eighty":-3.974726,"marketCap":73152717},{"date":"2023-07-28","current":-3.546317,"twenty":-18.384156,"median":-7.201618,"eighty":-3.956502,"marketCap":70827053},{"date":"2023-08-04","current":-3.592881,"twenty":-18.349739,"median":-7.160915,"eighty":-3.93091,"marketCap":71757024},{"date":"2023-08-11","current":-3.444503,"twenty":-18.137504,"median":-7.15835,"eighty":-3.920784,"marketCap":68793608},{"date":"2023-08-18","current":-2.948161,"twenty":-17.994102,"median":-7.123601,"eighty":-3.863042,"marketCap":58904262},{"date":"2023-08-25","current":-2.669745,"twenty":-17.955259,"median":-7.011512,"eighty":-3.835262,"marketCap":53341505},{"date":"2023-09-01","current":-2.976978,"twenty":-17.89555,"median":-6.993157,"eighty":-3.822281,"marketCap":59480011},{"date":"2023-09-08","current":-2.542614,"twenty":-17.822019,"median":-6.965625,"eighty":-3.811521,"marketCap":50801433},{"date":"2023-09-15","current":-2.468455,"twenty":-17.71877,"median":-6.915094,"eighty":-3.771793,"marketCap":49319725},{"date":"2023-09-22","current":-2.426078,"twenty":-17.667145,"median":-6.883029,"eighty":-3.718983,"marketCap":48473034},{"date":"2023-09-29","current":-2.415484,"twenty":-17.661835,"median":-6.856984,"eighty":-3.690753,"marketCap":48261361},{"date":"2023-10-06","current":-2.214193,"twenty":-17.636236,"median":-6.80961,"eighty":-3.659579,"marketCap":44239581},{"date":"2023-10-13","current":-1.980251,"twenty":-17.598312,"median":-6.754546,"eighty":-3.624757,"marketCap":39565422},{"date":"2023-10-20","current":-2.288554,"twenty":-17.523743,"median":-6.699481,"eighty":-3.58231,"marketCap":45725309},{"date":"2023-10-27","current":-2.252981,"twenty":-17.466382,"median":-6.699481,"eighty":-3.56025,"marketCap":45014553},{"date":"2023-11-03","current":-2.41899,"twenty":-17.391813,"median":-6.662772,"eighty":-3.546317,"marketCap":48331414},{"date":"2023-11-10","current":-2.288554,"twenty":-17.304698,"median":-6.589353,"eighty":-3.531279,"marketCap":45725309},{"date":"2023-11-17","current":-2.178562,"twenty":-17.149879,"median":-6.570998,"eighty":-3.505973,"marketCap":43227025},{"date":"2023-11-24","current":-2.334173,"twenty":-17.098914,"median":-6.552643,"eighty":-3.478451,"marketCap":46314670},{"date":"2023-12-01","current":-2.346144,"twenty":-17.022324,"median":-6.515934,"eighty":-3.46349,"marketCap":46552181},{"date":"2023-12-08","current":-2.836919,"twenty":-16.949803,"median":-6.479224,"eighty":-3.442885,"marketCap":56290137},{"date":"2023-12-15","current":-2.477815,"twenty":-16.925057,"median":-6.467164,"eighty":-3.432578,"marketCap":49164803},{"date":"2023-12-22","current":-1.496265,"twenty":-16.921454,"median":-6.42416,"eighty":-3.407935,"marketCap":29688891},{"date":"2023-12-29","current":-1.663847,"twenty":-16.915718,"median":-6.405805,"eighty":-3.364573,"marketCap":33014047},{"date":"2024-01-05","current":-1.695584,"twenty":-16.89851,"median":-6.405805,"eighty":-3.34012,"marketCap":33643786},{"date":"2024-01-12","current":-1.480473,"twenty":-16.87874,"median":-6.387451,"eighty":-3.281496,"marketCap":29375544},{"date":"2024-01-19","current":-1.290669,"twenty":-16.824266,"median":-6.369096,"eighty":-3.249023,"marketCap":25609449},{"date":"2024-01-26","current":-1.0338,"twenty":-16.696906,"median":-6.332386,"eighty":-3.205095,"marketCap":20512666},{"date":"2024-02-02","current":-0.646816,"twenty":-16.600233,"median":-6.314032,"eighty":-3.203217,"marketCap":12834128},{"date":"2024-02-09","current":-0.653022,"twenty":-16.577289,"median":-6.277322,"eighty":-3.193928,"marketCap":12957267},{"date":"2024-02-16","current":-0.672527,"twenty":-16.508456,"median":-6.194726,"eighty":-3.174121,"marketCap":13344276},{"date":"2024-02-23","current":-0.649223,"twenty":-16.446422,"median":-6.165475,"eighty":-3.13809,"marketCap":12881876},{"date":"2024-03-01","current":-0.626707,"twenty":-16.392461,"median":-6.13642,"eighty":-3.119242,"marketCap":13419668},{"date":"2024-03-08","current":-0.604507,"twenty":-16.347845,"median":-6.043444,"eighty":-3.086719,"marketCap":12944316},{"date":"2024-03-15","current":-0.539948,"twenty":-16.336373,"median":-6.031822,"eighty":-3.037469,"marketCap":11561914},{"date":"2024-03-22","current":-0.457797,"twenty":-16.307693,"median":-5.90979,"eighty":-3.001845,"marketCap":9802813},{"date":"2024-03-28","current":-0.365064,"twenty":-16.250332,"median":-5.706405,"eighty":-2.983977,"marketCap":7817112},{"date":"2024-04-05","current":-0.238289,"twenty":-16.024769,"median":-5.625051,"eighty":-2.958746,"marketCap":5102488},{"date":"2024-04-12","current":-0.306251,"twenty":-15.71519,"median":-5.52917,"eighty":-2.918711,"marketCap":6557744},{"date":"2024-04-19","current":-0.450382,"twenty":-15.453016,"median":-5.334501,"eighty":-2.841315,"marketCap":9644030},{"date":"2024-04-26","current":-0.561354,"twenty":-15.194892,"median":-5.069776,"eighty":-2.724673,"marketCap":12020274},{"date":"2024-05-03","current":-0.608414,"twenty":-15.170319,"median":-4.916109,"eighty":-2.66127,"marketCap":13027961},{"date":"2024-05-10","current":-0.517656,"twenty":-15.15399,"median":-4.882304,"eighty":-2.574397,"marketCap":11084564},{"date":"2024-05-17","current":-0.445886,"twenty":-14.962839,"median":-4.799889,"eighty":-2.544018,"marketCap":9285122},{"date":"2024-05-24","current":-0.341455,"twenty":-14.350128,"median":-4.694797,"eighty":-2.481196,"marketCap":7110458},{"date":"2024-05-31","current":-0.332309,"twenty":-14.32955,"median":-4.683289,"eighty":-2.468455,"marketCap":6920000},{"date":"2024-06-07","current":-0.320114,"twenty":-14.231403,"median":-4.68291,"eighty":-2.442705,"marketCap":6666055},{"date":"2024-06-14","current":-0.820102,"twenty":-14.17194,"median":-4.613937,"eighty":-2.429163,"marketCap":17077798},{"date":"2024-06-21","current":-0.746933,"twenty":-14.05445,"median":-4.603153,"eighty":-2.417588,"marketCap":15554128},{"date":"2024-06-28","current":-0.512182,"twenty":-13.986034,"median":-4.591759,"eighty":-2.404889,"marketCap":10665688},{"date":"2024-07-05","current":-0.503036,"twenty":-13.77177,"median":-4.557577,"eighty":-2.344112,"marketCap":10475229},{"date":"2024-07-12","current":-1.185946,"twenty":-13.57097,"median":-4.546183,"eighty":-2.334173,"marketCap":24696147},{"date":"2024-07-15","current":-2.024011,"twenty":-13.534162,"median":-4.546183,"eighty":-2.334173,"marketCap":42148012},{"date":"2024-08-02","current":-2.096274,"twenty":-13.516574,"median":-4.545194,"eighty":-2.334173,"marketCap":43652813},{"date":"2024-08-09","current":-1.758388,"twenty":-13.433225,"median":-4.520961,"eighty":-2.31064,"marketCap":36616668},{"date":"2024-08-16","current":-1.898646,"twenty":-13.364791,"median":-4.512001,"eighty":-2.29924,"marketCap":35324315},{"date":"2024-08-23","current":-2.029854,"twenty":-13.222936,"median":-4.500607,"eighty":-2.288554,"marketCap":37765427},{"date":"2024-08-30","current":-1.613078,"twenty":-12.914361,"median":-4.480896,"eighty":-2.277759,"marketCap":30011309},{"date":"2024-09-06","current":-1.667104,"twenty":-12.897094,"median":-4.462817,"eighty":-2.252981,"marketCap":31016472},{"date":"2024-09-13","current":-1.559051,"twenty":-12.854623,"median":-4.427985,"eighty":-2.217407,"marketCap":29006145},{"date":"2024-09-20","current":-1.589923,"twenty":-12.771457,"median":-4.406757,"eighty":-2.173128,"marketCap":29580524},{"date":"2024-09-27","current":-1.520461,"twenty":-12.501551,"median":-4.358253,"eighty":-2.075114,"marketCap":28288171},{"date":"2024-10-04","current":-1.381535,"twenty":-12.489283,"median":-4.29783,"eighty":-1.99284,"marketCap":25703465},{"date":"2024-10-11","current":-1.373817,"twenty":-12.472382,"median":-4.222264,"eighty":-1.970526,"marketCap":25559870},{"date":"2024-10-18","current":-1.705694,"twenty":-12.292987,"median":-4.207166,"eighty":-1.860056,"marketCap":31734446},{"date":"2024-10-25","current":-1.597641,"twenty":-12.243914,"median":-4.183922,"eighty":-1.813748,"marketCap":29724119},{"date":"2024-10-31","current":-1.667104,"twenty":-12.077063,"median":-4.181577,"eighty":-1.759454,"marketCap":31016472},{"date":"2024-11-08","current":-1.697976,"twenty":-12.005906,"median":-4.169657,"eighty":-1.745424,"marketCap":31590851},{"date":"2024-11-15","current":-1.666725,"twenty":-11.98873,"median":-4.149056,"eighty":-1.721811,"marketCap":29867714},{"date":"2024-11-22","current":-1.49845,"twenty":-11.899483,"median":-4.107516,"eighty":-1.702334,"marketCap":26852223},{"date":"2024-11-29","current":-1.697287,"twenty":-11.788297,"median":-4.084874,"eighty":-1.6977,"marketCap":30415388},{"date":"2024-12-06","current":-1.556537,"twenty":-11.581418,"median":-4.079031,"eighty":-1.693454,"marketCap":27893137},{"date":"2024-12-13","current":-1.539978,"twenty":-11.468548,"median":-4.06767,"eighty":-1.687171,"marketCap":27596401},{"date":"2024-12-20","current":-1.324712,"twenty":-11.370394,"median":-4.056243,"eighty":-1.669008,"marketCap":23738840},{"date":"2024-12-27","current":-1.523419,"twenty":-11.306598,"median":-4.044458,"eighty":-1.666877,"marketCap":27299666},{"date":"2025-01-03","current":-1.482022,"twenty":-11.23054,"median":-4.033455,"eighty":-1.660278,"marketCap":26557827},{"date":"2025-01-10","current":-1.49858,"twenty":-10.955726,"median":-4.021214,"eighty":-1.647611,"marketCap":26854562},{"date":"2025-01-17","current":-1.457183,"twenty":-10.946459,"median":-4.012979,"eighty":-1.632316,"marketCap":26112724},{"date":"2025-01-24","current":-1.407507,"twenty":-10.887398,"median":-3.998622,"eighty":-1.62215,"marketCap":25222517},{"date":"2025-01-31","current":-1.324712,"twenty":-10.772257,"median":-3.986348,"eighty":-1.60536,"marketCap":23738840},{"date":"2025-02-07","current":-1.332991,"twenty":-10.700305,"median":-3.974726,"eighty":-1.596984,"marketCap":23887207},{"date":"2025-02-14","current":-1.299874,"twenty":-10.597985,"median":-3.965092,"eighty":-1.589257,"marketCap":23293736},{"date":"2025-02-21","current":-1.35783,"twenty":-10.56684,"median":-3.958372,"eighty":-1.581873,"marketCap":24332311},{"date":"2025-02-28","current":-1.266756,"twenty":-10.5272,"median":-3.94548,"eighty":-1.573931,"marketCap":22700265},{"date":"2025-03-07","current":-1.337567,"twenty":-10.488832,"median":-3.93091,"eighty":-1.558045,"marketCap":21364956},{"date":"2025-03-14","current":-1.532696,"twenty":-10.409128,"median":-3.93091,"eighty":-1.545363,"marketCap":24481760},{"date":"2025-03-21","current":-1.644845,"twenty":-10.354484,"median":-3.896728,"eighty":-1.545363,"marketCap":26273109},{"date":"2025-03-28","current":-1.588771,"twenty":-10.300744,"median":-3.862959,"eighty":-1.549411,"marketCap":25377435},{"date":"2025-04-04","current":-1.355128,"twenty":-10.19785,"median":-3.839758,"eighty":-1.541216,"marketCap":21645459},{"date":"2025-04-11","current":-1.261671,"twenty":-10.150622,"median":-3.831813,"eighty":-1.530889,"marketCap":20152669},{"date":"2025-04-17","current":-1.317745,"twenty":-10.127971,"median":-3.8257,"eighty":-1.520461,"marketCap":21048343},{"date":"2025-04-25","current":-1.523351,"twenty":-10.088331,"median":-3.816971,"eighty":-1.504805,"marketCap":24332481},{"date":"2025-05-02","current":-1.457931,"twenty":-10.076006,"median":-3.808383,"eighty":-1.501012,"marketCap":23287528},{"date":"2025-05-09","current":-1.392511,"twenty":-10.05144,"median":-3.789482,"eighty":-1.497306,"marketCap":22242575},{"date":"2025-05-16","current":-1.234731,"twenty":-10.017545,"median":-3.736785,"eighty":-1.48758,"marketCap":20899064},{"date":"2025-05-23","current":-1.212683,"twenty":-10.009051,"median":-3.714425,"eighty":-1.481093,"marketCap":20525866},{"date":"2025-05-30","current":-1.155356,"twenty":-10.003388,"median":-3.705037,"eighty":-1.467119,"marketCap":19555552},{"date":"2025-06-06","current":-1.046377,"twenty":-9.980737,"median":-3.686096,"eighty":-1.457931,"marketCap":17710981},{"date":"2025-06-13","current":-1.170524,"twenty":-9.96658,"median":-3.662764,"eighty":-1.457183,"marketCap":19812283},{"date":"2025-06-20","current":-1.07298,"twenty":-9.909952,"median":-3.652178,"eighty":-1.450998,"marketCap":18161260},{"date":"2025-06-27","current":-1.152788,"twenty":-9.86748,"median":-3.625799,"eighty":-1.448585,"marketCap":19512097},{"date":"2025-07-03","current":-1.161656,"twenty":-9.837662,"median":-3.601459,"eighty":-1.423362,"marketCap":19662190},{"date":"2025-07-11","current":-1.330141,"twenty":-9.826049,"median":-3.578076,"eighty":-1.418476,"marketCap":22513959},{"date":"2025-07-18","current":-1.365611,"twenty":-9.825009,"median":-3.554442,"eighty":-1.406944,"marketCap":23114331},{"date":"2025-07-25","current":-1.498625,"twenty":-9.809964,"median":-3.546317,"eighty":-1.406944,"marketCap":25365727},{"date":"2025-08-01","current":-1.436552,"twenty":-9.796601,"median":-3.544917,"eighty":-1.404123,"marketCap":24315075},{"date":"2025-08-08","current":-1.126186,"twenty":-9.781204,"median":-3.52929,"eighty":-1.401702,"marketCap":19061818},{"date":"2025-08-15","current":-0.847058,"twenty":-9.704532,"median":-3.508713,"eighty":-1.392511,"marketCap":15705307},{"date":"2025-08-22","current":-0.654919,"twenty":-9.666972,"median":-3.483368,"eighty":-1.38321,"marketCap":12142860},{"date":"2025-08-29","current":-0.942693,"twenty":-9.645208,"median":-3.477287,"eighty":-1.374461,"marketCap":17478464},{"date":"2025-09-05","current":-0.849775,"twenty":-9.627466,"median":-3.468263,"eighty":-1.370734,"marketCap":15755680},{"date":"2025-09-12","current":-0.903049,"twenty":-9.60868,"median":-3.45354,"eighty":-1.364474,"marketCap":16743438},{"date":"2025-09-19","current":-0.874652,"twenty":-9.582972,"median":-3.44248,"eighty":-1.353259,"marketCap":16216915},{"date":"2025-09-26","current":-0.901459,"twenty":-9.546157,"median":-3.437042,"eighty":-1.331851,"marketCap":16713953},{"date":"2025-10-03","current":-0.869199,"twenty":-9.511694,"median":-3.424386,"eighty":-1.324712,"marketCap":16115822},{"date":"2025-10-10","current":-1.005168,"twenty":-9.490902,"median":-3.408699,"eighty":-1.31625,"marketCap":18636816},{"date":"2025-10-17","current":-0.939966,"twenty":-9.468971,"median":-3.365241,"eighty":-1.303452,"marketCap":17427918},{"date":"2025-10-24","current":-0.965524,"twenty":-9.443722,"median":-3.341253,"eighty":-1.298512,"marketCap":17901789},{"date":"2025-10-31","current":-0.951098,"twenty":-9.426918,"median":-3.327009,"eighty":-1.287727,"marketCap":17634315},{"date":"2025-11-07","current":-0.759895,"twenty":-9.422117,"median":-3.280813,"eighty":-1.275035,"marketCap":16216915},{"date":"2025-11-14","current":-0.689538,"twenty":-9.417519,"median":-3.245855,"eighty":-1.261671,"marketCap":14715421},{"date":"2025-11-21","current":-0.60317,"twenty":-9.388971,"median":-3.220645,"eighty":-1.256034,"marketCap":12872260},{"date":"2025-11-28","current":-0.663447,"twenty":-9.357706,"median":-3.205095,"eighty":-1.24523,"marketCap":14158633},{"date":"2025-12-05","current":-0.632459,"twenty":-9.327916,"median":-3.204662,"eighty":-1.229108,"marketCap":13497313},{"date":"2025-12-12","current":-0.626761,"twenty":-9.270052,"median":-3.196481,"eighty":-1.214441,"marketCap":13375716},{"date":"2025-12-19","current":-0.55099,"twenty":-9.194084,"median":-3.193928,"eighty":-1.195218,"marketCap":11758684},{"date":"2025-12-26","current":-0.532197,"twenty":-9.178733,"median":-3.180007,"eighty":-1.18264,"marketCap":11357625},{"date":"2026-01-02","current":-0.505807,"twenty":-9.165415,"median":-3.173699,"eighty":-1.177559,"marketCap":10794437},{"date":"2026-01-09","current":-0.628761,"twenty":-9.14547,"median":-3.13809,"eighty":-1.161656,"marketCap":13418382},{"date":"2026-01-16","current":-0.563785,"twenty":-9.088841,"median":-3.126922,"eighty":-1.152788,"marketCap":12031744},{"date":"2026-01-23","current":-0.548491,"twenty":-9.038591,"median":-3.120114,"eighty":-1.142147,"marketCap":11705351},{"date":"2026-01-30","current":-0.579579,"twenty":-8.985674,"median":-3.104108,"eighty":-1.125846,"marketCap":12368804},{"date":"2026-02-06","current":-0.510806,"twenty":-8.919918,"median":-3.082252,"eighty":-1.09839,"marketCap":10901102}],"updateTime":1770704118527},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGVN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609309579","title":"Longeveron ‘applauds’ Mikaela Naylon Give Kids a Chance Act passage","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609309579?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:21","pubTimestamp":1770301261,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) supports and applauds Congress passing the Mikaela Naylon Give Kids a Chance Act. The Mikaela Naylon Give Kids a Chance Act reaut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-applauds-mikaela-naylon-give-kids-a-chance-act-passage-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-applauds-mikaela-naylon-give-kids-a-chance-act-passage-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2609060713","title":"Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2609060713","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609060713?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:15","pubTimestamp":1770300900,"startTime":"0","endTime":"0","summary":"Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3233093/0/en/Longeveron-Applauds-Passage-of-the-Mikaela-Naylon-Give-Kids-a-Chance-Act-and-Reauthorization-of-Rare-Pediatric-Disease-Priority-Review-Voucher-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4575","BK4139","AD","MSC","LGVN","BK4150","BK4132"],"gpt_icon":0},{"id":"2607503371","title":"Longeveron granted Japan patent for potency assay methods for MSCs","url":"https://stock-news.laohu8.com/highlight/detail?id=2607503371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607503371?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:21","pubTimestamp":1769696468,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that the Japan Patent Office, JPO, has granted a patent covering potency assay methods for assessing human mesenchymal ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-granted-japan-patent-for-potency-assay-methods-for-mscs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-granted-japan-patent-for-potency-assay-methods-for-mscs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2607033935","title":"Longeveron Granted Japan Patent for Potency Assay Methods for Human Mesenchymal Stem Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2607033935","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607033935?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:15","pubTimestamp":1769696109,"startTime":"0","endTime":"0","summary":"Longeveron Inc. has been granted a patent by the Japan Patent Office covering potency assay methods for assessing human mesenchymal stem cells  derived from various sources, including bone marrow, adipose tissue, peripheral blood, and others, as well as MSCs differentiated from induced pluripotent stem cells. The patent, titled \"Potency Assay\" , provides protection in Japan through April 20, 2041, assuming all annuity fees are paid. This issuance expands Longeveron's international patent portfolio, supporting its clinical programs and products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief via GlobeNewswire  on January 29, 2026, and is solely responsible f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL64VmFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","SG9999014039.USD","SG9999014013.SGD","BK4588","LU2210150020.SGD","LU2095319765.USD","BK4139","SG9999014021.USD","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","LGVN","LU0314104364.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2606246650","title":"Longeveron granted FDA Type C Meeting ahead of ELPIS II data readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2606246650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606246650?lang=en_us&edition=fundamental","pubTime":"2026-01-26 22:21","pubTimestamp":1769437284,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that the U.S. Food and Drug Administration has granted Longeveron a Type C meeting at the end of March to prepare for t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-granted-fda-type-c-meeting-ahead-of-elpis-ii-data-readout-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-granted-fda-type-c-meeting-ahead-of-elpis-ii-data-readout-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2606524687","title":"Longeveron Inc - Elpis Ii Trial Results Anticipated in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2606524687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606524687?lang=en_us&edition=fundamental","pubTime":"2026-01-26 22:15","pubTimestamp":1769436900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUAXM6LW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2606246257","title":"Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606246257","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606246257?lang=en_us&edition=fundamental","pubTime":"2026-01-26 22:15","pubTimestamp":1769436900,"startTime":"0","endTime":"0","summary":"ELPIS II top-line trial results are anticipated in the third quarter of 2026Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated if ELPIS II","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/26/3225715/0/en/Longeveron-Announces-FDA-Grants-Type-C-Meeting-Ahead-of-Data-Readout-for-Pivotal-Phase-2-Clinical-Trial-ELPIS-II-Evaluating-Treatment-for-Hypoplastic-Left-Heart-Syndrome-HLHS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4023","BK4613","BK4139","LGVN","BK4528","MSC","AD","BK4575","BK4588","SAP","BK4132","BK4150"],"gpt_icon":0},{"id":"2595735550","title":"Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2595735550","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595735550?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:15","pubTimestamp":1767017700,"startTime":"0","endTime":"0","summary":"Mission-aligned community focused on accelerating breakthroughs in Alzheimer’s disease, Parkinson’s disease and related conditionsSupported by Health Moonshot Champions, including the Alzheimer’s Drug","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/29/3210983/0/en/Longeveron-Selected-as-a-StartUp-Health-Alzheimer-s-Disease-Moonshot-Company-Will-Participate-in-StartUp-Health-Apollo-House-During-JPM-Healthcare-Week-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","LU0345770993.USD","LU2756315318.SGD","BK4137","IE00B775SV38.USD","LU0251132253.USD","HCSG","XBI","LU0787776722.HKD","LU1720051017.SGD","LU1720051108.HKD","LGVN","IE00BLSP4239.USD","BK4575","LU2430703095.HKD","LU2023250330.USD","LU2746668974.SGD","LU2756315664.SGD","LU0971096721.USD","LU1629891620.HKD","BK4581","IE00BFXG1179.USD","LU1267930490.SGD","LU2430703251.USD","LU2106854487.HKD","IE00BLSP4452.SGD","LABU","LU0106261372.USD","LU1917777945.USD","IE00BZ1G4Q59.USD","LU0320765489.SGD","LU1548497426.USD","LU2430703178.SGD","LU0211327993.USD","XLV","MSC","LU1670627923.USD","LU1551013425.SGD","IE00BBT3K403.USD","SG9999002232.USD","IE00BHPRN162.USD","LU0170899867.USD","LU0106831901.USD","LU2746668461.USD","IE00BN8TJ469.HKD","LU2264538146.SGD","LU0128526141.USD","LU1363072403.SGD","LU0683600562.USD","LU1084165304.USD"],"gpt_icon":0},{"id":"2592915817","title":"Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using Its Proprietary Stem Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592915817?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:15","pubTimestamp":1765980944,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XN0PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2592915849","title":"Longeveron Granted U.S. Patent for Stem Cell Therapy to Treat Female Sexual Dysfunction","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592915849?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:15","pubTimestamp":1765980911,"startTime":"0","endTime":"0","summary":"Longeveron Inc. has been granted a U.S. patent covering the administration of its proprietary mesenchymal stem cells  for the treatment of female patients with sexual dysfunction and for improving sexual quality of life. The newly issued patent, U.S. Patent No. 12,496,316, provides rights through 2038 and may be eligible for further term or regulatory exclusivity extensions. The patent relates to methods of administering effective amounts of isolated allogeneic MSCs to address female sexual dysfunction, a condition affecting up to 46% of women and often lacking effective treatment options. Longeveron plans to pursue licensing or partnering agreements for the development and commercialization of stem cell therapy for this indication.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL5LWXPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4585","LGVN","LU2095319765.USD","BK4588","BK4139","NDAQ"],"gpt_icon":0},{"id":"2588286044","title":"Longeveron Executives Speak at Global CardioVascular Clinical Trialists Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2588286044","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588286044?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:15","pubTimestamp":1764771309,"startTime":"0","endTime":"0","summary":"Longeveron Inc., a clinical stage biotechnology company, announced that its Chief Science Officer, Dr. Joshua Hare, and Chief Medical Officer, Dr. Nataliya Agafonova, will participate as speakers at the Global CardioVascular Clinical Trialists  Forum, taking place December 8-10, 2025, in Washington, D.C. The executives will contribute to panel discussions focused on cell therapy heart failure trials, delivery routes for cell therapies, and strategies for advancing innovation in cell therapy clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief via GlobeNewswire  on December 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLc1LG58:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4585","LGVN","LU2095319765.USD","LU0314104364.USD","BK4588","LU2210150020.SGD","LU2210149790.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2588402044","title":"Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global Cardiovascular Clinical Trialists (Cvct) Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2588402044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588402044?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:15","pubTimestamp":1764771300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUAJTP0C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2588005961","title":"Longeveron Granted Canadian Patent for Stem Cell Therapy Targeting Aging-Related Frailty and Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2588005961","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588005961?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:15","pubTimestamp":1764684922,"startTime":"0","endTime":"0","summary":"Longeveron Inc. has been granted Canadian Patent No. 3043594, titled \"Method of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity.\" The patent covers methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells  for the treatment of aging-related frailty with inflammaging and non-ischemic dilated cardiomyopathy. The patent provides rights in Canada through 2037. Laromestrocel, the company's proprietary MSC therapy, has shown positive initial results in clinical trials for aging-related frailty, a syndrome with no approved treatments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief via Globe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLFH2c9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU2210150020.SGD","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","LGVN","LU0314104364.USD"],"gpt_icon":0},{"id":"2588059653","title":"Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-Related Frailty in Patients With Inflammaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588059653?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:15","pubTimestamp":1764684900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA9ZZJPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2588477449","title":"Longeveron Stem Cell Therapy Reduces Neuroinflammation in Mild Alzheimer’s Disease, Phase 2 Trial Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2588477449","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588477449?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:00","pubTimestamp":1764608425,"startTime":"0","endTime":"0","summary":"Longeveron Inc. announced new data from its Phase 2 placebo-controlled CLEAR-MIND clinical trial evaluating laromestrocel, a stem cell therapy, in patients with mild Alzheimer's disease. The results, presented at the 18th Clinical Trials on Alzheimer's Disease Conference , showed that treatment with laromestrocel was associated with a reduction in MRI-measured neuroinflammation across multiple key brain regions, including the hippocampus. The reduction in hippocampal neuroinflammation correlated with preservation of hippocampal volume and clinical outcomes. The findings support the continued development of laromestrocel for mild Alzheimer's disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL2gZhhX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LGVN","LU2095319765.USD","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","NDAQ","BK4112","BK4585","LU2210150020.SGD","LU0314104364.USD"],"gpt_icon":0},{"id":"2588741747","title":"Longeveron New Mri Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients With Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (Ctad 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588741747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588741747?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:00","pubTimestamp":1764608400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA1MDRPH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2584427039","title":"Longeveron Highlights Laromestrocel Data Showing Reduced Brain Neuroinflammation in Mild Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2584427039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584427039?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:15","pubTimestamp":1763561710,"startTime":"0","endTime":"0","summary":"Longeveron Inc. announced that data from its clinical study evaluating laromestrocel in mild Alzheimer's disease has been selected for poster presentation at the 18th Clinical Trials on Alzheimer's Disease Conference , scheduled for December 1-4, 2025, in San Diego, California. The presentation, titled \"Reduced brain neuroinflammation after laromestrocel treatment in mild AD: results from the CLEAR MIND study,\" will share findings related to neuroinflammation outcomes following laromestrocel treatment. The results are set to be presented at the conference and have not yet been disclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief via GlobeNewswire  on N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL3V5QLt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","BK4588","BK4139","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4585","LGVN","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ"],"gpt_icon":0},{"id":"2584429329","title":"Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (Ctad 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584429329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584429329?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:15","pubTimestamp":1763561700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA6ZQLBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2582537734","title":"Longeveron granted U.S. patent for administration of MSCs","url":"https://stock-news.laohu8.com/highlight/detail?id=2582537734","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582537734?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:11","pubTimestamp":1762956690,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that the United States Patent and Trademark Office, USPTO, has granted a patent covering administration of the Company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-granted-u-s-patent-for-administration-of-mscs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-granted-u-s-patent-for-administration-of-mscs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2582637215","title":"Longeveron Granted U.S. Patent for Stem Cell Therapy Targeting Aging-Related Frailty","url":"https://stock-news.laohu8.com/highlight/detail?id=2582637215","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582637215?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:05","pubTimestamp":1762956314,"startTime":"0","endTime":"0","summary":"Longeveron Inc. announced that the United States Patent and Trademark Office has granted a patent for methods of treating aging-related frailty in patients with inflammaging using its proprietary mesenchymal stem cell  therapy. The patent, which is valid through 2038, covers the administration of isolated allogeneic MSCs to address symptoms such as weakness, low physical activity, slowed motor performance, exhaustion, and unintentional weight loss in older individuals. The company's lead MSC therapy, laromestrocel, has shown positive initial results in two clinical trials targeting aging-related frailty.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief via Gl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL702vWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LGVN","LU2095319765.USD","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","NDAQ","BK4112","BK4585","LU2210150020.SGD","LU0314104364.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}